RELAPSED ADVANCED LYMPHOMAS
Clinical trials for RELAPSED ADVANCED LYMPHOMAS explained in plain language.
Never miss a new study
Get alerted when new RELAPSED ADVANCED LYMPHOMAS trials appear
Sign up with your email to follow new studies for RELAPSED ADVANCED LYMPHOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to tame advanced lymphomas in early trial
Disease control Recruiting nowThis early-stage study tests an experimental oral drug called AUR108 in adults with relapsed advanced lymphomas. The main goals are to check the drug's safety, find the right dose, and see how the body processes it. About 40 participants will take the pill, and researchers will m…
Matched conditions: RELAPSED ADVANCED LYMPHOMAS
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Apr 26, 2026 19:38 UTC
-
New pill AUR112 tested in patients with returning lymphoma
Disease control Recruiting nowThis early-stage study tests an experimental oral drug called AUR112 in about 40 adults with relapsed advanced lymphoma (a type of blood cancer that has come back). The main goals are to check the drug's safety, find the right dose, and see how the body processes it. Participants…
Matched conditions: RELAPSED ADVANCED LYMPHOMAS
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Apr 24, 2026 16:06 UTC